XML 94 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
Selected Quarterly Data
12 Months Ended
Dec. 31, 2014
Selected Quarterly Financial Information [Abstract]  
Selected Quarterly Data
 
Three Months Ended
 
March 31,
2014
 
June 30,
2014
 
September 30, 2014
 
December 31, 2014
Revenue
$
464.7

 
$
512.2

 
$
550.1

 
$
604.7

Gross profit
$
315.4

 
$
344.4

 
$
360.6

 
$
393.4

Net income (1)(2)
$
44.3

 
$
104.0

 
$
123.7

 
$
146.8

Net income per common share
 
 
 
 
 
 
 
Basic
$
1.16

 
$
2.82

 
$
3.43

 
$
4.03

Diluted
$
1.13

 
$
2.77

 
$
3.35

 
$
3.94

 
 
 
 
 
 
 
 
(1) Includes one-time discrete tax benefits as follows:
 
 
 
 
 
 
 
      Audit settlement and expiration of the statutes of limitations in multiple jurisdictions
$
0.2

 
$

 
$
0.2

 
$
19.9

Reinstatement of the 2014 federal R&D tax credit
$

 
$

 
$

 
$
5.0

(2) Includes pre-tax charges relating to tolled product liability claims
$
67.4

 
$
9.6

 
$

 
$
5.4

 
 
 
 
 
 
 
 
 
Three Months Ended
 
March 31,
2013
 
June 30,
2013
 
September 30, 2013
 
December 31, 2013
Revenue
$
611.4

 
$
578.5

 
$
499.0

 
$
576.2

Gross profit
$
434.3

 
$
405.2

 
$
356.7

 
$
398.0

Net income (1)
$
188.9

 
$
159.1

 
$
156.8

 
$
166.2

Net income per common share
 
 
 
 
 
 
 
Basic
$
4.69

 
$
3.99

 
$
4.06

 
$
4.36

Diluted
$
4.56

 
$
3.90

 
$
3.99

 
$
4.28

 
 
 
 
 
 
 
 
(1) Includes one-time discrete tax benefits as follows:
 
 
 
 
 
 
 
Expiration of the statutes of limitations in multiple jurisdictions
$

 
$

 
$
26.2

 
$
0.5

Reinstatement of the 2012 federal R&D tax credit
$
7.5

 
$

 
$

 
$
0.7